Envista (NVST) Competitors $18.70 +0.67 (+3.72%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends NVST vs. SOLV, SNN, PEN, GKOS, BLCO, INSP, PRCT, AXNX, NVCR, and NARIShould you be buying Envista stock or one of its competitors? The main competitors of Envista include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry. Envista vs. Solventum Smith & Nephew Penumbra Glaukos Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics Axonics NovoCure Inari Medical Solventum (NYSE:SOLV) and Envista (NYSE:NVST) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation. Do analysts rate SOLV or NVST? Solventum presently has a consensus target price of $68.29, indicating a potential upside of 2.18%. Envista has a consensus target price of $20.65, indicating a potential upside of 10.45%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Envista 2 Sell rating(s) 11 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.06 Is SOLV or NVST more profitable? Solventum has a net margin of 0.00% compared to Envista's net margin of -53.42%. Envista's return on equity of 3.76% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A Envista -53.42%3.76%2.24% Does the media refer more to SOLV or NVST? In the previous week, Solventum had 13 more articles in the media than Envista. MarketBeat recorded 14 mentions for Solventum and 1 mentions for Envista. Solventum's average media sentiment score of 1.24 beat Envista's score of 0.63 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 10 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation & earnings, SOLV or NVST? Solventum has higher revenue and earnings than Envista. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.26B1.40N/AN/AN/AEnvista$2.50B1.29-$100.20M-$7.77-2.41 Does the MarketBeat Community prefer SOLV or NVST? Envista received 33 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 37.78% of users gave Envista an outperform vote while only 5.56% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes15.56%Underperform Votes1794.44% EnvistaOutperform Votes3437.78% Underperform Votes5662.22% SummaryEnvista beats Solventum on 7 of the 12 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Envista News Delivered to You Automatically Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVST vs. The Competition Export to ExcelMetricEnvistaDental equipment & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$3.22B$3.80B$5.12B$19.18BDividend YieldN/A1.74%4.91%3.59%P/E Ratio-2.4136.7891.3441.28Price / Sales1.291.511,116.5917.59Price / Cash7.6511.1942.6421.28Price / Book0.771.054.795.32Net Income-$100.20M-$33.08M$120.07M$989.88M7 Day Performance-3.95%-0.60%-1.89%-3.54%1 Month Performance-12.58%-1.91%11.45%-3.68%1 Year Performance-23.38%115.25%30.61%12.14% Envista Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVSTEnvista3.9074 of 5 stars$18.70+3.7%$20.65+10.4%-21.1%$3.22B$2.50B-2.4112,800Positive NewsHigh Trading VolumeSOLVSolventum1.298 of 5 stars$69.77+0.3%$68.29-2.1%N/A$12.05BN/A0.0022,000Positive NewsSNNSmith & Nephew3.7112 of 5 stars$25.51-0.1%N/A-7.3%$11.15B$5.55B13.0318,452News CoveragePENPenumbra4.225 of 5 stars$247.93+1.0%$252.42+1.8%-1.8%$9.52B$1.16B285.524,200Analyst ForecastGKOSGlaukos4.1194 of 5 stars$143.83+3.5%$143.17-0.5%+89.5%$7.93B$360.35M-46.00780Analyst ForecastShort Interest ↓BLCOBausch + Lomb3.1618 of 5 stars$18.56-0.2%$20.58+10.9%+16.9%$6.54B$4.68B-17.7113,300INSPInspire Medical Systems4.6583 of 5 stars$188.59+0.4%$233.58+23.9%+1.7%$5.65B$755.59M176.781,011Positive NewsPRCTPROCEPT BioRobotics2.7661 of 5 stars$89.09-0.2%$97.86+9.8%+102.9%$4.65B$136.19M0.00626Positive NewsAXNXAxonics1.4263 of 5 stars$70.98+0.8%$71.00+0.0%+20.9%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.4937 of 5 stars$32.75-2.0%$32.67-0.3%+138.4%$3.54B$577.74M-23.861,453NARIInari Medical3.3112 of 5 stars$55.12-0.8%$58.89+6.8%-11.9%$3.23B$574.50M-41.181,300Analyst ForecastInsider Trade Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Glaukos Alternatives Bausch + Lomb Alternatives Inspire Medical Systems Alternatives PROCEPT BioRobotics Alternatives Axonics Alternatives NovoCure Alternatives Inari Medical Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NVST) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envista Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envista With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.